Tg Therapeutics (TGTX) Minority Interest (2011 - 2012)
Tg Therapeutics' Minority Interest came in at $8.52 million for Q2 2012, down 2.8% from the prior quarter.
Powered by 
Analysis
Tg Therapeutics (TGTX) Minority Interest (2011 - 2012) Analysis & Trends
At the end of FY2012, Tg Therapeutics' Minority Interest was $9.45 million.
- Going back by year, Minority Interest was $11,681 in FY2011.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Tg Therapeutics | 8.54 Bn | 7.93 Bn | 199.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2012 | 8.52 Mn |
| Jun 30, 2012 | 8.77 Mn |
| Mar 31, 2012 | 9.45 Mn |
| Dec 31, 2011 | 11,681.00 |
API Access
Tg Therapeutics Minority Interest API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=minority-interest&ticker=TGTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "minority-interest", "ticker": "TGTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=minority-interest&ticker=TGTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();